Should antianginal medication be stopped for exercise testing?
- 18 July 1992
- journal article
- Published by Elsevier in The Lancet
- Vol. 340 (8812) , 161-162
- https://doi.org/10.1016/0140-6736(92)93226-d
Abstract
No abstract availableKeywords
This publication has 10 references indexed in Scilit:
- Effect on prognosis of abolition of exercise-induced painless myocardial ischemia by medical therapyThe American Journal of Cardiology, 1992
- Prognostic significance of a predischarge exercise test in risk stratification after unstable angina pectorisJournal of the American College of Cardiology, 1991
- Early prognosis after thrombolysis: value of exercise radionuclide ventriculography performed on anti-ischaemic medicationThe International Journal of Cardiovascular Imaging, 1991
- Prognostic importance of failure of medical therapy to normalise exercise ejection fraction responce in coronary artery diseaseJournal of the American College of Cardiology, 1991
- Usefulness of low-level exercise testing early after acute myocardial infarction in patients taking beta-blocking agentsThe American Journal of Cardiology, 1987
- Effect of beta-adrenergic blockade on the results of exercise testing related to the extent of coronary artery diseaseThe American Journal of Cardiology, 1985
- Exercise testing provides additional prognostic information in angiographically defined subgroups of patients with coronary artery disease.Circulation, 1983
- Accurate detection of coronary heart disease by new exercise test.Heart, 1982
- Accuracy of diagnosis of coronary artery disease by radionuclide management of left ventricular function during rest and exercise.Circulation, 1981
- Exercise first-pass radionuclide ventriculography in detection of coronary artery disease.Heart, 1980